Provider Recommendation and HPV Vaccination

NARecruitingINTERVENTIONAL
Enrollment

301,201

Participants

Timeline

Start Date

March 21, 2022

Primary Completion Date

December 31, 2025

Study Completion Date

June 30, 2026

Conditions
Human Papillomavirus
Interventions
OTHER

Local Tailoring implementation strategy

"The local-tailored approach will be guided by a structured process involving the following: (1) convening a local HPV vaccine project team, (2) conducting a local diagnostic process to identify top barriers, (3) selecting from a menu of intervention options that will be offered in this study, categorized by core function (i.e., the forms and functions menu) that address top local barriers, and (4) deploying the selected interventions. The barrier assessment and intervention customization are key processes for the local-tailored strategy, which allow clinics to devote resources to respond to unique local barriers in addition to common barriers."

OTHER

Prescribed Strategy

"The prescribed strategy is the standard implementation approach used by most health systems. Our prescribed approach will be guided by the evidence-based, award-winning 4 Pillars™ Practice Transformation Program for improving vaccination rates in the outpatient setting. The 4 Pillars™ address 4 main functions, i.e., convenience, communication, office systems, and motivation to guide the selection of interventions. For adolescent HPV vaccination, the 4 Pillars has demonstrated moderate effectiveness."

Trial Locations (1)

91101

RECRUITING

Kaiser Permanente Southern California, Pasadena

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Kaiser Permanente

OTHER